- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02639949
Measuring and Improving Medication Adherence in Kidney Transplant Patients
September 12, 2017 updated by: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
The Use of Random Telephone Calls to Measure Immunosuppressive Therapy Adherence in Patients With Renal Transplants
Nonadherence to medication is a major obstacle to successful treatment of renal transplant patients.
This study has two primary aims.
The first is to test whether a culturally sensitive cognitive-behavioral adherence promotion program could significantly improve medication adherence to tacrolimus prescription.
Participants will be randomly assigned to either group CBT or to standard care.
The second aim is to pilot a novel strategy of adherence measurement - unannounced telephone pill counts, which has been shown to be a valid and reliable means to measure medication adherence in other patient populations.
Participants will be recruited from waiting area of the kidney transplant clinic at SUNY Downstate Medical Center in Brooklyn, NY.
Three unannounced telephone pill counts will be conducted prior to start of the intervention in order to establish baseline adherence and three pill counts will be conducted post-intervention.
Tacrolimus trough concentration levels will also be collected as an additional biological measure of adherence.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
45
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- current prescription of tacrolimus less than 98% adherence to medication prescription as determined by three baseline pill counts
Exclusion Criteria:
- lack of telephone to complete pill counts lack of English proficiency to participate in adherence promotion sessions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group CBT
|
A culturally sensitive group cognitive behavioral therapy combined with adherence promotion.
|
Active Comparator: Standard Care
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Adherence as measured by unannounced telephone pill count
Time Frame: 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
degree of agreement between pill count data and laboratory tacrolimus levels
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2010
Primary Completion (Actual)
September 1, 2013
Study Completion (Actual)
July 1, 2017
Study Registration Dates
First Submitted
December 17, 2015
First Submitted That Met QC Criteria
December 21, 2015
First Posted (Estimate)
December 28, 2015
Study Record Updates
Last Update Posted (Actual)
September 13, 2017
Last Update Submitted That Met QC Criteria
September 12, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- NIDDK_KUH
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Transplant Recipients
-
University of CincinnatiUniversity of Colorado, Denver; Children's Hospital Medical Center, CincinnatiCompletedLiver Transplant Recipients | Kidney Transplant RecipientsUnited States
-
National Institute of Allergy and Infectious Diseases...Genomics of Transplantation Cooperative Research ProgramCompletedKidney Transplant Donor | KidneyTransplant Recipients | Simultaneous Kidney/Pancreas RecipientsUnited States, Canada
-
National Institute of Allergy and Infectious Diseases...Bristol-Myers Squibb; Clinical Trials in Organ TransplantationCompletedKidney Transplant Recipients | Living-Donor Kidney TransplantUnited States
-
Seoul National University HospitalSamsung Medical Center; Asan Medical Center; Korea University; Yonsei University; Gachon University Gil Medical Center and other collaboratorsUnknownKidney Transplant Recipients | Complications After Kidney TransplantKorea, Republic of
-
National Institute of Allergy and Infectious Diseases...University of PittsburghRecruitingKidney Transplant | Renal Transplant RecipientsUnited States
-
National Institute of Allergy and Infectious Diseases...Genomics of Transplantation Cooperative Research ProgramCompletedKidney Transplant RecipientsUnited States
-
National Institute of Allergy and Infectious Diseases...Clinical Trials in Organ TransplantationTerminatedKidney Transplant RecipientsUnited States, Canada
-
Astellas Pharma China, Inc.Terminated
-
Astellas Pharma China, Inc.CompletedKidney Transplant RecipientsChina
-
Dokuz Eylul UniversityRecruitingKidney Transplant RecipientsTurkey
Clinical Trials on Cognitive-behavioral adherence promotion program
-
Florida State UniversityCompleted
-
Florida State UniversityCompletedMild Cognitive Impairment | Ketosis | Adherence, PatientUnited States
-
University of the Balearic IslandsUnknownDepressive Disorder, Treatment-ResistantSpain
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulCompleted
-
Universidad de GranadaCompletedStress, Psychological | Vision Disorders | Self Efficacy | PsychopathySpain
-
Massachusetts General HospitalUniversity of Miami; University of Maryland; University of Stellenbosch; University... and other collaboratorsNot yet recruitingHIV Infections
-
Ohio State UniversityRecruitingObstructive Sleep Apnea | Adherence, PatientUnited States
-
Beni-Suef UniversityCompletedDepression | Insomnia | Cognitive Behavioral Therapy | Menopausal DepressionEgypt
-
Jamaica Hospital Medical CenterCompleted
-
Virginia Polytechnic Institute and State UniversityNational Institute of Mental Health (NIMH)CompletedAutistic Disorder | Child Development Disorders, PervasiveUnited States